Zaixiang Tan

Zaixiang Tan


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
XZXiaoning Zhang
Xiaoning Zhang
YGYuqing Guo
Yuqing Guo
QZQiong Zhou
Qiong Zhou
ZTZaixiang Tan
Zaixiang Tan
JCJunli Cao
Junli Cao
Background: Vaccine hesitancy, associated with medical mistrust, confidence, complacency and knowledge of vaccines, presents an obstacle to the campaign against the coronavirus disease 2019 (COVID-19). The relationship between vaccine hesitancy and conspiracy beliefs may be a key determinant of the success of vaccination campaigns. This study provides a conceptual framework to explain the impact of pathways from conspiracy beliefs to COVID-19 vaccine hesitancy with regard to medical mistrust, confidence, complacency and knowledge of vaccines. Methods: A non-probability study was conducted with 1015 respondents between 17 April and 28 May 2021. Conspiracy beliefs were measured using the coronavirus conspiracy scale of Coronavirus Explanations, Attitudes, and Narratives Survey (OCEANS), and vaccine conspiracy beliefs scale. Medical mistrust was measured using the Oxford trust in doctors and developers questionnaire, and attitudes to doctors and medicine scale. Vaccine confidence and complacency were measured using the Oxford COVID-19 vaccine confidence and complacency scale. Knowledge of vaccines was measured using the vaccination knowledge scale. Vaccine hesitancy was measured using the Oxford COVID-19 vaccine hesitancy scale. Confirmatory factor analysis (CFA) was used to evaluate the measurement models for conspiracy beliefs, medical mistrust, confidence, complacency, and knowledge of vaccines and vaccine hesitancy. The structural equation modeling (SEM) approach was used to analyze the direct and indirect pathways from conspiracy beliefs to vaccine hesitancy. Results: Of the 894 (88.1%) respondents who were willing to take the COVID-19 vaccine without any hesitancy, the model fit with the CFA models for conspiracy beliefs, medical mistrust, confidence, complacency and knowledge of vaccines, and vaccine hesitancy was deemed acceptable. Conspiracy beliefs had significant direct (β = 0.294), indirect (β = 0.423) and total (β = 0.717) effects on vaccine hesitancy; 41.0% of the total effect was direct, and 59.0% was indirect. Conspiracy beliefs significantly predicted vaccine hesitancy by medical mistrust (β = 0.210), confidence and complacency (β = 0.095), knowledge (β = 0.079) of vaccines, explaining 29.3, 11.0, and 13.2% of the total effects, respectively. Conspiracy beliefs significantly predicted vaccine hesitancy through the sequential mediation of knowledge of vaccines and medical mistrust (β = 0.016), explaining 2.2% of the total effects. Conspiracy beliefs significantly predicted vaccine hesitancy through the sequential mediation of confidence and complacency, and knowledge of vaccines (β = 0.023), explaining 3.2% of the total effects. The SEM approach indicated an acceptable model fit (χ2/df = 2.464, RMSEA = 0.038, SRMR = 0.050, CFI = 0.930, IFI = 0.930). Conclusions: The sample in this study showed lower vaccine hesitancy, and this study identified pathways from conspiracy beliefs to COVID-19 vaccine hesitancy in China. Conspiracy beliefs had direct and indirect effects on vaccine hesitancy, and the indirect association was determined through medical mistrust, confidence, complacency, and knowledge of vaccines. In addition, both direct and indirect pathways from conspiracy beliefs to vaccine hesitancy were identified as intervention targets to reduce COVID–19 vaccine hesitancy.

20 November 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YLYao Luo
Yao Luo
SWSujing Wei
Sujing Wei
JYJing Yang
Jing Yang
ZTZaixiang Tan
Zaixiang Tan
The main purpose of this study was to construct two nomograms to predict all-cause mortality (ACM) and cause-specific mortality (CSM) in non-muscle-invasive bladder cancer (NMIBC) patients after transurethral resection of bladder tumors (TURBTs). We selected NMIBC patients who underwent TURBT between 2004 and 2017 from the Surveillance, Epidemiology, and End Results database. The patients were randomly divided into a training set and a validation set at a ratio of 7:3. The independent influencing factors of ACM and CSM in the training set were determined by univariate and multivariate Cox regression analyses. We then integrated those independent influencing factors to construct nomograms. These prediction nomograms were further verified in the validation set. The C-index, calibration curve, receiver operating characteristic (ROC) curve and decision curve analysis (DCA) curve were used to evaluate the identification, calibration, predictive ability and clinical effectiveness of the nomograms. A total of 28,086 cases were ultimately included in this study, which were divided into a training set (19,661 individuals) and a validation set (8425 individuals). Nine variables, including age at diagnosis, race, marital status, tumor grade, T stage, tumor size, number of tumors, and primary site, were obtained via multivariate Cox regression of the training set and used to construct two nomograms prediction model. The C-index values for the ACM nomogram were 0.743 and 0.741 for the training and validation sets, respectively. Moreover, the corresponding values of the C-index for the CSM nomogram were 0.785 and 0.786, respectively. The ROC curves, calibration curves, and DCA curves showed good predictive performance. The nomograms can assist clinicians in identifying high-risk populations and devising more individualized treatment strategies for NMIBC patients.

16 April 2026 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
YGYing Guan
Ying Guan
YXYu Xiang
Yu Xiang
YFYan Fu
Yan Fu
LHLeyao Huang
Leyao Huang
SSShiyu Su
Shiyu Su
XHXinru Huang
Xinru Huang
Background: Against the backdrop of deep integration between population aging and digital technologies, smart aging care has emerged as a pivotal approach to alleviating caregiving pressures, optimizing resource allocation for senior care, and driving high-quality development of the silver economy. As a top-level institutional design, the quality of smart aging care policies directly determines the effectiveness of older adult care services and the inclusiveness of digital technology applications in older adult care. Conducting a scientific and systematic quantitative evaluation of such policy documents is essential. This study aims to quantitatively evaluate the overall quality and regional heterogeneity of China's smart aging care policies, identify policy shortcomings, and propose optimization pathways for improvement. Methods: The PMC-Index model is the quantitative policy evaluation method that constructs a multi-dimensional indicator system and assigns equal weights to each indicator. Based on this, this study has constructed an evaluation index system for the PMC model of smart aging care policies. This study systematically reviewed 83 smart aging care policies issued by China's government from 2020 to 2025.10 representative policies were selected based on screening criteria that encompass regional coverage across eastern, central, and western regions, uneven economic development, reflection of aging disparities, and responsiveness to the digitalization process.The PMC index was calculated through integrated methods including text mining and multi-input-output tables, combined with visual analysis to evaluate policy structures and regional heterogeneity, thereby identifying optimization pathways. Results: The findings indicate that the overall quality of China's smart aging healthcare policies has reached the “excellent” level, characterized by clear objectives, comprehensive domain coverage, and rigorous textual logic, demonstrating the strong orientation toward technology empowerment and industrial synergy. However, challenges remain: insufficient policy continuity, imbalanced tool mixes, and underdeveloped safeguards. Moreover, policy quality exhibits regional heterogeneity, with eastern regions prioritizing innovation and industrial cultivation, whereas central and western regions focus more on basic service provision and inclusive implementation. Conclusion: This study employs the PMC-Index model to conduct the multidimensional quantitative assessment of China's smart aging care policies. This research provides the reference framework for optimizing and refining smart aging care policies in China, which may also offer insights for other countries and regions addressing population aging and fostering silver economy development. Ultimately, it aims to support the coordinated advancement and continuous improvement of global smart aging care policies.

19 August 2026 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
YGYing Guan
Ying Guan
XCXianhao Chen
Xianhao Chen
TZTing Zhang
Ting Zhang
LZLiyu Zhao
Liyu Zhao
RMRu Meng
Ru Meng
XHXinru Huang
Xinru Huang
Background: Readmission is an important indicator of healthcare quality, reflecting continuity of care, treatment outcomes, and the quality of discharge management. However, existing readmission prediction studies have primarily focused on 30-day readmission as the primary outcome, with limited attention to differences in the underlying risk mechanisms, predictive performance, and clinical applicability across different readmission time windows. Meanwhile, under the context of China’s multi-payment reform and the Coordinated Tripartite Medical Reform, limited evidence is available on the development of readmission prediction models based on real-world data and their application to healthcare quality monitoring and the management of high-risk patients. Therefore, this study aimed to develop and validate 15-day and 30-day all-cause same-hospital readmission prediction models using real-world hospitalization data, compare the predictive factors and model performance across different readmission time windows, and provide empirical evidence to support healthcare quality monitoring and risk management under the ongoing payment reform. Methods: A single-center retrospective design was adopted, and data from 57,677 hospitalizations at a large tertiary hospital in China between January 2021 and July 2025 were collected. Multivariable logistic regression models were developed for 15-day and 30-day all-cause same-hospital readmissions, respectively. Model performance was evaluated using the AUC, Brier score, calibration plots, bootstrap internal validation, and temporal external validation. Differences in predictor associations between the two readmission time horizons were further examined. Results: The 15-day and 30-day readmission rates were 9.47 and 10.92%, respectively. The 15-day model achieved an AUC of 0.840 (95% CI: 0.828–0.843) and a Brier score of 0.0620; the 30-day model achieved an AUC of 0.820 (95% CI: 0.810–0.825) and a Brier score of 0.0735. Both AUCs were statistically significant. Both models demonstrated good discrimination and calibration, with the 15-day model consistently outperforming the 30-day model across all performance metrics. In the temporal external validation, the model achieved an AUC of 0.810 and a Brier score of 0.136, indicating good generalizability. Age, LOS, surgical status, and number of secondary diagnoses were independently associated with higher odds of readmission (overall p < 0.05), while higher total cost was associated with lower odds of readmission. Risk stratification showed that the observed readmission rate exceeded 58% in the highest-risk decile and was below 2% in the lowest-risk group. Conclusion: This study developed and validated dual-time-horizon readmission prediction models based on real-world data, extending the conventional approach of single-horizon readmission risk assessment. The models provide a methodological framework for risk stratification and healthcare quality monitoring across different post-discharge periods. They may support early discharge risk screening, facilitate prioritization of transitional care resources for high-risk patients, and provide empirical evidence to inform quality assessment, risk adjustment, and management decision-making under the multi-payment reform and the Coordinated Tripartite Medical Reform.

17 October 2023 in Research Square
Verified
Preprint
Open access
PDF file
XLXinyu Liu
Xinyu Liu
YLYitian Liu
Yitian Liu
MHMengqin Huang
Mengqin Huang
JZJingjing Zhou
Jingjing Zhou
WWWenjian Wu
Wenjian Wu
ZTZaixiang Tan
Zaixiang Tan
Objective Thousands of Budd-Chiari syndrome (BCS) cases are reported in Jiangsu, Shandong, Anhui, and other places in China. It is of great significance to investigate and analyze BCS cases in high-incidence areas. The study aims to understand factors associated with hospitalization expenditures for patients with BCS. Methods In this retrospective study from January 1, 2013, to December 31, 2020, we included 1748 patients from a tertiary hospital. Influencing factors associated with BCS hospitalization expenditures were evaluated by multiple linear regression model analyses. Results Medicare began to have an effect on hospitalization expenditures when the patient's overall costs reached ¥15,000 or more and contributed more when the expenses were between ¥15,000 and ¥29,999. The length of stay in hospital for BCS did not always have an effect on total costs, but rather exerted an effect at the lowest (<¥15,000) and highest (>¥45,000) levels. In contrast, the type of surgery was associated with cost increase only at the lowest total cost level. Complications and discharge cure were the same and had an impact intermittently. Conclusions To continuously reduce the hospitalization expenditures of BCS patients, this study suggests improving the health insurance system, shortening the length of hospital stay, controlling the types of surgery performed, and so on.